Researchers are now exploring how to best extract and use saliva-derived DNA for long-read sequencing applications. Download ...

The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery.

Illumina has unveiled a database of genomic alterations, called the Billion Cell Atlas, that can be used to identify and ...

Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech company at ...

Agreement grants access to Synaffix patent portfolio related to metal-free click chemistry Technology to be used in Illumina's next-generation sequencing (NGS) products AMSTERDAM, Dec. 4, 2024 ...

Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

Scientists sequence hundreds of thousands of genomes for crucial large-scale research efforts, such as population genomics initiatives that process more than 10,000 samples per year, to explore ...

Discover GRAIL’s MCED screening tests, Illumina’s divestiture impact, and an $8B valuation base with TAM upside tied to FDA ...